Longbio Pharma

This is an early-stage study to check the safety and how the body processes a new injection called LP-003 in teenagers with allergic diseases. It will involve 6 participants aged 12 to 18 who have conditions like food allergies, asthma, or eczema. The main goal is to see how safe…

This study is testing an investigational injection called LP-005 in adults with paroxysmal nocturnal hemoglobinuria (PNH), a rare blood disease where the immune system attacks and destroys red blood cells. Researchers will measure if the treatment reduces blood cell destruction, …

This study is testing whether an investigational injection called LP-003 can reduce symptoms in adults with moderate-to-severe seasonal allergies (hay fever) that aren't well controlled by standard allergy medicines. It's a large, late-stage trial comparing the injection to a pla…

This is a very early, first-in-human study to check the safety and basic effects of a single dose of a new drug called LP-003. It involves 12 healthy adults and will measure how their bodies react to and process the drug. The goal is to gather initial safety data to see if LP-003…